GPCM
CELGZ

Granite Point Capital Management’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Granite Point Capital Management’s Portfolio CELGZ Stock Details CELGZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-65,000
Closed -$178K – 136
2013
Q4 		$178K Buy
+65,000
New +$182K 0.03% 97

Other funds holding CELGZ

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
FA
FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
WJA
Williams Jones & Associates New York $4.82B AUM 19.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Granite Point Capital Management's CELGZ Position: Q1 2014 in Review

Granite Point Capital Management sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q1 2014, closing a stake of 65,000 shares — an estimated $178K sold.

Granite Point Capital Management first reported a position in CELGZ in Q4 2013 and held it in 1 quarter. The position peaked at $178K in Q4 2013. 23 funds tracked by Wall St. Rank hold CELGZ as of Q1 2014.

  • Granite Point Capital Management reported no remaining Celgene Corporation Contingent Value Rights position as of Q1 2014 after selling out during the quarter.
  • Granite Point Capital Management sold 65,000 Celgene Corporation Contingent Value Rights shares in Q1 2014, an estimated $178K.
  • Granite Point Capital Management first reported a position in Celgene Corporation Contingent Value Rights in Q4 2013 and held it in 1 quarter.
  • Granite Point Capital Management's Celgene Corporation Contingent Value Rights position peaked at $178K in Q4 2013.
  • 23 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q1 2014.

Based on Granite Point Capital Management's 13F filing for Q1 2014, filed 14 May 2014.